IsoRay PE Ratio 2006-2018 | ISR

Current and historical p/e ratio for IsoRay (ISR) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. IsoRay PE ratio as of April 17, 2019 is 0.00.
IsoRay PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-04-18 0.39 0.00
2018-12-31 0.30 $-0.10 0.00
2018-09-30 0.52 $-0.11 0.00
2018-06-30 0.45 $-0.12 0.00
2018-03-31 0.42 $-0.11 0.00
2017-12-31 0.40 $-0.11 0.00
2017-09-30 0.52 $-0.11 0.00
2017-06-30 0.63 $-0.11 0.00
2017-03-31 0.59 $-0.10 0.00
2016-12-31 0.58 $-0.10 0.00
2016-09-30 0.72 $-0.09 0.00
2016-06-30 0.87 $-0.08 0.00
2016-03-31 0.90 $-0.08 0.00
2015-12-31 0.94 $-0.08 0.00
2015-09-30 1.40 $-0.08 0.00
2015-06-30 1.48 $-0.06 0.00
2015-03-31 1.57 $-0.07 0.00
2014-12-31 1.46 $-0.10 0.00
2014-09-30 1.69 $-0.10 0.00
2014-06-30 3.12 $-0.16 0.00
2014-03-31 2.20 $-0.16 0.00
2013-12-31 0.50 $-0.13 0.00
2013-09-30 0.67 $-0.14 0.00
2013-06-30 0.48 $-0.11 0.00
2013-03-31 0.54 $-0.12 0.00
2012-12-31 0.78 $-0.12 0.00
2012-09-30 0.72 $-0.11 0.00
2012-06-30 1.01 $-0.12 0.00
2012-03-31 0.48 $-0.11 0.00
2011-12-31 0.66 $-0.13 0.00
2011-09-30 0.99 $-0.12 0.00
2011-06-30 0.94 $-0.12 0.00
2011-03-31 1.26 $-0.14 0.00
2010-12-31 1.13 $-0.15 0.00
2010-09-30 1.25 $-0.18 0.00
2010-06-30 1.43 $-0.18 0.00
2010-03-31 1.32 $-0.18 0.00
2009-12-31 0.89 $-0.19 0.00
2009-09-30 1.10 $-0.22 0.00
2009-06-30 0.25 $-0.26 0.00
2009-03-31 0.17 $-0.21 0.00
2008-12-31 0.20 $-0.24 0.00
2008-09-30 0.60 $-0.29 0.00
2008-06-30 0.60 $-0.30 0.00
2008-03-31 1.00 $-0.30 0.00
2007-12-31 2.01 $-0.33 0.00
2007-09-30 3.51 $-0.33 0.00
2007-06-30 5.04 $-0.43 0.00
2007-03-31 3.95 $-0.43 0.00
2006-12-31 4.90 $-0.42 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.027B $0.006B
IsoRay, Inc. is a medical technology company that produces therapeutic radioactive isotopes. Through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. The Cs-131 includes radioisotope in the treatment of all malignant tumors, such as prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma and pancreatic cancer. The Company's Proxcelan Cesium-131 seed is classified as a Class II device. The Company competes with Varian Medical Systems, Siemens Healthcare, Elekta AB and Accuray Incorporated.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.954B 31.20
Takeda Pharmaceutical (TAK) Japan $28.872B 10.68
Grifols (GRFS) Spain $12.960B 15.84
Ionis Pharmaceuticals (IONS) United States $10.057B 31.19
Sage Therapeutics (SAGE) United States $7.604B 0.00
Neurocrine Biosciences (NBIX) United States $7.369B 477.29
Jazz Pharmaceuticals (JAZZ) Ireland $7.285B 10.43
Catalent (CTLT) United States $6.226B 26.07
Nektar Therapeutics (NKTR) United States $5.430B 8.66
Tilray (TLRY) United States $4.722B 0.00
United Therapeutics (UTHR) United States $4.401B 7.48
Taro Pharmaceutical Industries (TARO) Israel $4.054B 13.05
FibroGen (FGEN) United States $3.948B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.737B 0.00
Portola Pharmaceuticals (PTLA) United States $2.206B 0.00
PTC Therapeutics (PTCT) United States $2.060B 0.00
USANA Health Sciences (USNA) United States $1.943B 16.31
Aerie Pharmaceuticals (AERI) United States $1.827B 0.00
Heron Therapeutics (HRTX) United States $1.776B 0.00
Xencor (XNCR) United States $1.748B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.732B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.721B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.655B 20.61
Madrigal Pharmaceuticals (MDGL) United States $1.638B 0.00
Endo (ENDP) Ireland $1.604B 2.47
Zogenix (ZGNX) United States $1.547B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.508B 130.61
Corcept Therapeutics (CORT) United States $1.369B 19.88
Tricida (TCDA) United States $1.345B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.264B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.076B 0.00
Esperion Therapeutics (ESPR) United States $1.076B 0.00
Radius Health (RDUS) United States $1.016B 0.00
TherapeuticsMD (TXMD) United States $1.013B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.847B 0.00
Akebia Therapeutics (AKBA) United States $0.810B 0.00
CannTrust Holdings (CTST) Canada $0.768B 0.00
ChemoCentryx (CCXI) United States $0.709B 0.00
ArQule (ARQL) United States $0.692B 0.00
Odonate Therapeutics (ODT) United States $0.597B 0.00
Dermira (DERM) United States $0.597B 0.00
Forty Seven (FTSV) United States $0.588B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.578B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.561B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.540B 0.00
GlycoMimetics (GLYC) United States $0.517B 0.00
Translate Bio (TBIO) United States $0.468B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.464B 23.97
Collegium Pharmaceutical (COLL) United States $0.454B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.447B 0.00
KalVista Pharmaceuticals (KALV) United States $0.438B 0.00
Siga Technologies (SIGA) United States $0.425B 0.00
OptiNose (OPTN) United States $0.421B 0.00
TCR2 THERAPTCS (TCRR) United States $0.417B 0.00
Aptorum Group (APM) China $0.392B 0.00
Flexion Therapeutics (FLXN) United States $0.389B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.388B 0.00
ImmunoGen (IMGN) United States $0.378B 0.00
Mast Therapeutics (SVRA) United States $0.323B 0.00
CASI Pharmaceuticals (CASI) United States $0.320B 0.00
Harpoon Therapy (HARP) United States $0.307B 0.00
Karyopharm Therapeutics (KPTI) United States $0.293B 0.00
Minerva Neurosciences (NERV) United States $0.279B 0.00
Lannett Co Inc (LCI) United States $0.276B 2.57
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.274B 10.14
Verrica Pharmaceuticals (VRCA) United States $0.272B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.265B 0.00
Xeris Pharmaceuticals (XERS) United States $0.255B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.248B 0.00
Calithera Biosciences (CALA) United States $0.239B 0.00
Dova Pharmaceuticals (DOVA) United States $0.235B 0.00
Concert Pharmaceuticals (CNCE) United States $0.232B 0.00
Opexa Therapeutics (ACER) United States $0.229B 0.00
Molecular Templates (MTEM) United States $0.224B 0.00
Ardelyx (ARDX) United States $0.217B 0.00
Affimed (AFMD) Germany $0.215B 0.00
Aclaris Therapeutics (ACRS) United States $0.214B 0.00
MEI Pharma (MEIP) United States $0.211B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.209B 0.00
Aldeyra Therapeutics (ALDX) United States $0.202B 0.00
Rafael Holdings (RFL) United States $0.200B 0.00
Galectin Therapeutics (GALT) United States $0.200B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.194B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.189B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.186B 0.00
Jounce Therapeutics (JNCE) United States $0.185B 0.00
Recro Pharma (REPH) United States $0.181B 0.00
IMV INC (IMV) Canada $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.179B 186.20
Majesco Entertainment (PTE) United States $0.177B 0.00
Neon Therapeutics (NTGN) United States $0.176B 0.00
Redhill Biopharma (RDHL) Israel $0.174B 0.00
Aratana Therapeutics (PETX) United States $0.173B 0.00
Tyme Technologies (TYME) United States $0.168B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.168B 0.00
AgeX Therapeutics (AGE) United States $0.168B 0.00
ElectroCore (ECOR) United States $0.164B 0.00
Ocular Therapeutix (OCUL) United States $0.156B 0.00
Aquestive Therapeutics (AQST) United States $0.156B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.147B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.142B 0.00
China SXT Pharmaceuticals (SXTC) China $0.124B 0.00
MediWound (MDWD) Israel $0.121B 0.00
Iterum Therapeutics (ITRM) Ireland $0.119B 0.00
Cardiome Pharma (CORV) Canada $0.109B 0.00
ProNAi Therapeutics (SRRA) Canada $0.107B 0.00
Nivalis Therapeutics (ALPN) United States $0.101B 0.00
Neos Therapeutics (NEOS) United States $0.100B 0.00
Zafgen (ZFGN) United States $0.100B 0.00
Natural Alternatives (NAII) United States $0.097B 9.49
Oasmia Pharmaceutical AB (OASM) Sweden $0.097B 0.00
DURECT (DRRX) United States $0.094B 0.00
Adherex Technologies (FENC) United States $0.094B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.090B 0.00
Infinity Pharmaceuticals (INFI) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.088B 0.00
Champions Oncology (CSBR) United States $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
SCYNEXIS (SCYX) United States $0.081B 0.00
Otonomy (OTIC) United States $0.078B 0.00
Genocea Biosciences (GNCA) United States $0.077B 0.00
Avenue Therapeutics (ATXI) United States $0.073B 0.00
India Globalization Capital (IGC) United States $0.067B 0.00
Capnia (SLNO) United States $0.063B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.057B 0.00
Forward Pharma (FWP) Denmark $0.056B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.054B 0.00
Bio-Path Holdings (BPTH) United States $0.051B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Melinta Therapeutics (MLNT) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
ContraFect (CFRX) United States $0.047B 0.00
Lipocine (LPCN) United States $0.046B 0.00
KemPharm (KMPH) United States $0.044B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.043B 0.00
BioLineRx (BLRX) Israel $0.040B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.039B 0.00
Heat Biologics (HTBX) United States $0.038B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.034B 0.00
HANCOCK JAFFE (HJLI) United States $0.032B 0.00
Shineco (TYHT) China $0.028B 4.65
Summit Therapeutics (SMMT) United Kingdom $0.027B 3.53
PharmAthene (ALT) United States $0.026B 0.00
Achieve Life Sciences (ACHV) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
NOVAN INC (NOVN) United States $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Jaguar Animal Health (JAGX) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.016B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.83
Achaogen (AKAO) United States $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
Can-Fite Biopharma (CANF) Israel $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.009B 0.00
Trillium Therapeutics (TRIL) Canada $0.008B 0.00
VAXART, INC (VXRT) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00